The inaugural New Horizons Forum brought together highly respected leaders in medicine, science, business, venture capital, and philanthropy to share the latest advances in glaucoma therapies and research.
Held on Friday, February 3, 2012 at the Palace Hotel in San Francisco, this meeting fostered important collaborations that broadened our understanding of glaucoma and will ultimately lead to innovative new treatments for patients with glaucoma. Here are some photos from the event.
Dr. H. Dunbar Hoskins, Jr. interviewed James Mazzo, President and CEO
of Abbott Medical Optics.
Dr. George A. Cioffi delivered the keynote, speaking on the State of Glaucoma Therapy in 2012.
Transcend Medical President and CEO
Brian Walsh was one of many CEO
s from companies developing new glaucoma devices to present at New Horizons. Jay Wei, President/CEO of Optovue (left) was also on the panel.
The full-day program engaged audience members across the spectrum of glaucoma research, diagnostics, and therapeutics. Pictured: Craig C. Taylor, Alloy Ventures.
Coffee breaks throughout the day allowed for networking opportunities. Pictured L-R: Dipali Apte, MD,
PhD (Kaiser Permanente), Shan Lin, MD (UCSF), and Kathryn Najafi-Tagol, MD (Eye Institute of Marin).
Attendees interacted with companies showing new products in the exhibit hall.
The Venture Capital Panel discussion included (L-R) William J. Link, PhD (Versant Ventures), Wende Hutton (Canaan Partners), Eugene de Juan, Jr., MD (ForSight Labs), and Anand Mehra, MD (Sofinnova Ventures).
"New Horizons at the FDA
" (L-R) Gary D. Novack, PhD (PharmaLogic), Wiley A. Chambers, MD (FDA), Ellen Strahlman, MD, MHS
c (GlaxoSmithKline), and Malvina B. Eydelman, MD (FDA).
Glaucoma 360 New Horizons Forum
Read more about the New Horizons Forum.
Last reviewed on
October 29, 2017